Source: World Journal of Nuclear Medicine. Conference titles: Congress of the World Federation of Nuclear Medicine & Biology. Unidade: FM
Subjects: DOR, MEDULA ÓSSEA (EFEITOS DE DROGAS), GRUPOS CONTROLE, DOENÇAS DA MEDULA ÓSSEA (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAPIENZA, Marcelo Tatit et al. Bone pain palliation and medullary toxicity after (Sm153)-EDTMP treatment: relation to the extent of disease and dosimetry. World Journal of Nuclear Medicine. London, UK: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 02 nov. 2025. , 2002APA
Sapienza, M. T., Ono, C. R., Watanabe, T., Costa, P. L. A., Guimarães, M. I. C., & Buchpiguel, C. A. (2002). Bone pain palliation and medullary toxicity after (Sm153)-EDTMP treatment: relation to the extent of disease and dosimetry. World Journal of Nuclear Medicine. London, UK: Faculdade de Medicina, Universidade de São Paulo.NLM
Sapienza MT, Ono CR, Watanabe T, Costa PLA, Guimarães MIC, Buchpiguel CA. Bone pain palliation and medullary toxicity after (Sm153)-EDTMP treatment: relation to the extent of disease and dosimetry. World Journal of Nuclear Medicine. 2002 ; 1[citado 2025 nov. 02 ]Vancouver
Sapienza MT, Ono CR, Watanabe T, Costa PLA, Guimarães MIC, Buchpiguel CA. Bone pain palliation and medullary toxicity after (Sm153)-EDTMP treatment: relation to the extent of disease and dosimetry. World Journal of Nuclear Medicine. 2002 ; 1[citado 2025 nov. 02 ]
